240
Participants
Start Date
April 22, 2020
Primary Completion Date
August 30, 2022
Study Completion Date
March 17, 2026
AZD9833
Dosage formulation: AZD9833 tablets will be administered orally.
Fulvestrant
Dosage formulation: Fulvestrant will be administered via intramuscular (IM) injection.
Research Site, Budapest
Research Site, Brasschaat
Research Site, Leuven
Research Site, Debrecen
Research Site, Nyíregyháza
Research Site, Namur
Research Site, Umbria
Research Site, Charleroi
Research Site, Batumi
Research Site, Kecskemét
Research Site, Szeged
Research Site, Libramont-Chevigny
Research Site, Haine-Saint-Paul
Research Site, Kaposvár
Research Site, Pécs
Research Site, Ghent
Research Site, Goyang-si
Research Site, Berlin
Research Site, Cherkasy
Research Site, Milan
Research Site, Milan
Research Site, Monza
Research Site, Nahariya
Research Site, Madrid
Research Site, Madrid
Research Site, St. Petersburg
Research Site, Fort Myers
Research Site, Birmingham
Research Site, Nashville
Research Site, Chattanooga
Research Site, Bologna
Research Site, Düsseldorf
Research Site, Seville
Research Site, Canton
Research Site, Essen
Research Site, Meldola
Research Site, Dnipro
Research Site, Zaragoza
Research Site, Vandœuvre-lès-Nancy
Research Site, Eagle River
Research Site, Chernivtsі
Research Site, Lincoln
Research Site, Paris
Research Site, Napoli
Research Site, Uzhhorod
Research Site, Catanzaro
Research Site, Long Beach
Research Site, Jerusalem
Research Site, Messina
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Kursk
Research Site, Krasnodar
Research Site, Pyatigorsk
Research Site, Ryazan
Research Site, Volgograd
Research Site, Kazan'
Research Site, Petah Tikva
Research Site, Jerusalem
Research Site, Greenfield Park
Research Site, Montreal
Research Site, Montreal
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Roma
Research Site, Bydgoszcz
Research Site, Lodz
Research Site, Piła
Research Site, Rzeszów
Research Site, Skorzewo
Research Site, Warsaw
Research Site, Almada
Research Site, Lisbon
Research Site, Lisbon
Research Site, Lisbon
Research Site, Lisbon
Research Site, Loures
Research Site, Porto
Research Site, Incheon
Research Site, Barcelona
Research Site, Barcelona
Research Site, Kyiv
Research Site, M. Kyiv
Research Site, S. Khodosivka
Research Site, Derby
Research Site, Leicester
Lead Sponsor
AstraZeneca
INDUSTRY